2024-04-08 LIDR Meeting Notes

Date

Apr 8, 2024

Attendees

(Bolded indicates presence at meeting)

Name	Organization

Name	Organization
Hung Luu	Children’s
Riki Merrick	Vernetzt, APHL
Andrea Pitkus	UW
Pam Banning	3M - Solventum
Xavier Gansel	Biomerieux
Amy McCormick	Epic
Dan Rutz	Epic
Rob Rae	CAP
Rob Hausam	Hausam Consulting
Sandy Jones	CDC
Stan Huff	Graphite
Ed Heierman	Abbott / IICC
Andrew Quinn
Laurent Lardin	Biomerieux
Anthony Killeen	UMN
Craig Collom
Marti Velezis	Sonrisa / FDA
Walter Sujansky	FDA
Susan Downer	JMC
Ralf Herzog	Roche
Cornelia Felder	Roche
Daniel Golson	JMC
Andrea Prada	JMC
Maria Sagat	CAP
Raja Cholan	FDA
Russ Ott	FDA
Akila Namasivayam	FDA
Desiree Mustaquim	CDC
Christina Gallegos	APHL
John Spinosa	Lantana

Agenda and Notes

Topic	Notes

Topic	Notes
Reviewing minutes from the last call - Action Item Follow up	Pull out the definitions from LIVD for test kit and equipment and put here: SHIELD Glossary Review operational definition of “equivalence” Outreach to Dr. DeBaca Hung will check for more info and maybe see, if she could participate in SHIELD Keep updating the googlesheet: Potassium LIVD data Shared Reportable Conditions LIVD google sheet for crowdsourcing with CSTE - added sign up sheet for PHAs to specific conditions and see how that develops Have LIVD File Repository Requirements Have draft budget (for setting up a web-based database and yearly maintenance): https://aphlinformatics.atlassian.net/wiki/download/attachments/915407143/LIDR - Budget.xlsx?api=v2 Review LIDR Use Cases and sign up to lead one of these - prioritize these use cases, so that we can finalize the requirements for the first phase of LIDR Define next steps to migrate existing LIVD files into FHIR LIVD catalog format and find a FHIR server to host Riki to see, if Marti can share the LIDR categorical data to instance data mapping for each element
Call Schedule	send OOO via chat or email
LIDR Elements Discussion	Not today
Review LIDR White Paper	From last week: Raja added a sentence - Xavier to review to see, if that reolves his comments - done Will start with “Roadmap for LIDR - Riki” review - goal of this section is to take the requirements Stan wrote up and put them in temporal order to create something useful right away and then expand on that Discussion: Why splitting into content and tooling - to help a reader see a place where they can help need to be more clear about the timing aspect - add expected duration and starting points (POST-CALL thought: highlight steps that can be started right now vs those that have dependencies) LIDR can have observationDefinitions for all the additional clinical context needed to successfully convert IVD vendor provided attributes into the lab’s test compendium address situations for LOINC system = XXX (or clinical specimen) - in the future support the SCT mapping for these, when not granularly represented in LOINC (and even if it is, should still be SCT encoded and provided) Would be good to provide tooling to convert excel to FHIR representation Next Steps: Draft more content identifying steps in the roadmap - labeling as content vs tooling (or both, if applicable) and provide a bit more of a timeline for each step
ACTION ITEMS	Please see the action items at top of this page - Next deliverable is White paper draft by end of this month
Next call	Monday 4/15/2024 9 - 10 AM ET
Adjourned	9:55 AM ET

From Chat:

Recording:

Action items:

Quick decisions not requiring context or tracking

For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.

Decisions requiring context or tracking

For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.